BlackRock’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39.3M | Buy |
|
|||||
|
2025
Q2 | $14.5M | Buy |
|
|||||
|
2025
Q1 | $20.9M | Buy |
|
|||||
|
2024
Q4 | $31.3M | Sell |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $31M | Buy |
|
|||||
|
2024
Q1 | $7.61M | Buy |
|
|||||
|
2023
Q4 | $6.32M | Buy |
|
|||||
|
2023
Q3 | $1.93M | Buy |
|
|||||
|
2023
Q2 | $1.82M | Sell |
|
|||||
|
2023
Q1 | $7.67M | Sell |
|
|||||
|
2022
Q4 | $34.3M | Buy |
|
|||||
|
2022
Q3 | $30.5M | Buy |
|
|||||
|
2022
Q2 | $27.3M | Buy |
|
|||||
|
2022
Q1 | $17.5M | Buy |
|
|||||
|
2021
Q4 | $11.2M | Buy |
|
|||||
|
2021
Q3 | $24.2M | Sell |
|
|||||
|
2021
Q2 | $44.1M | Sell |
|
|||||
|
2021
Q1 | $60.2M | Buy |
|
|||||
|
2020
Q4 | $53.7M | Buy |
|
|||||
|
2020
Q3 | $75.3M | Sell |
|
|||||
|
2020
Q2 | $107M | Buy |
|
|||||
|
2020
Q1 | $61.6M | Sell |
|
|||||
|
2019
Q4 | $123M | Sell |
|
|||||
|
2019
Q3 | $77.5M | Buy |
|
|||||
|
2019
Q2 | $92.3M | Buy |
|
|||||
|
2019
Q1 | $74.6M | Sell |
|
|||||
|
2018
Q4 | $86.4M | Sell |
|
|||||
|
2018
Q3 | $83.4M | Buy |
|
|||||
|
2018
Q2 | $70.7M | Buy |
|
|||||
|
2018
Q1 | $108M | Sell |
|
|||||
|
2017
Q4 | $99.1M | Sell |
|
|||||
|
2017
Q3 | $76.3M | Buy |
|
|||||
|
2017
Q2 | $59.2M | Sell |
|
|||||
|
2017
Q1 | $45.3M | Buy |
|
|||||
|
2016
Q4 | $41K | Sell |
|
|||||
|
2016
Q3 | $47K | Hold |
|
|||||
|
2016
Q2 | $34K | Buy |
|
|||||
|
2016
Q1 | $15K | Buy |
|
|||||
|
2015
Q4 | $8K | Hold |
|
|||||
|
2015
Q3 | $9K | Hold |
|
|||||
|
2015
Q2 | $31K | Sell |
|
|||||
|
2015
Q1 | $443K | Buy |
|